Uni-Bio Science Group Ltd (UNBSF)
0.004
0.00 (0.00%)
USD |
OTCM |
Nov 14, 16:00
Uni-Bio Science Group Enterprise Value: 13.51M for Nov. 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 14, 2024 | 13.51M |
| November 13, 2024 | 13.51M |
| November 12, 2024 | 13.51M |
| November 11, 2024 | 13.51M |
| November 08, 2024 | 13.51M |
| November 07, 2024 | 13.51M |
| November 06, 2024 | 13.51M |
| November 05, 2024 | 13.51M |
| Date | Value |
|---|---|
| November 04, 2024 | 13.51M |
| November 01, 2024 | 13.51M |
| October 31, 2024 | 13.51M |
| October 30, 2024 | 13.51M |
| October 29, 2024 | 13.51M |
| October 28, 2024 | 13.51M |
| October 25, 2024 | 13.51M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
13.51M
Minimum
Oct 25 2024
13.51M
Maximum
Oct 25 2024
13.51M
Average
13.51M
Median
Oct 25 2024
Enterprise Value Benchmarks
| Sino Biopharmaceutical Ltd | 8.600B |
| HUTCHMED (China) Ltd | 2.171B |
| Pharmaron Beijing Co Ltd | -- |
| Regencell Bioscience Holdings Ltd | 71.42M |
| Prenetics Global Ltd | 9.425M |
Enterprise Value Related Metrics
| Earnings Yield | 50.52% |
| Operating Earnings Yield | 50.89% |
| Normalized Earnings Yield | 50.52 |